{"id":"standard-statin-monotherapy","safety":{"commonSideEffects":[{"rate":"null","effect":"Muscle pain"},{"rate":"null","effect":"Liver enzyme elevation"},{"rate":"null","effect":"Diabetes"}]},"_chembl":{"chemblId":"CHEMBL261657","moleculeType":"Small molecule","molecularWeight":"405.37"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This inhibition leads to a decrease in the production of cholesterol in the liver, resulting in lower levels of low-density lipoprotein (LDL) cholesterol in the blood. Statins also have pleiotropic effects, including anti-inflammatory and antioxidant properties.","oneSentence":"Standard statin monotherapy works by inhibiting HMG-CoA reductase, a key enzyme in the cholesterol biosynthesis pathway.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:36:23.745Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypercholesterolemia"},{"name":"Atherosclerotic cardiovascular disease"}]},"trialDetails":[{"nctId":"NCT06975111","phase":"PHASE2, PHASE3","title":"Focusing on the Menopausal Transition to Improve Mid-Life Women's Health","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-03-01","conditions":"Menopause, Menopause Hot Flashes, Menopause Related Conditions","enrollment":200},{"nctId":"NCT06336174","phase":"","title":"Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study","status":"RECRUITING","sponsor":"Anhui Medical University","startDate":"2022-11-01","conditions":"Intracranial Atherosclerosis, Cognitive Impairment, Cerebrovascular Event","enrollment":100},{"nctId":"NCT04850001","phase":"","title":"Cognitive Decline in Asymptomatic Intracranial Stenosis Patients: A 1-Year Follow-Up Study","status":"UNKNOWN","sponsor":"Anhui Medical University","startDate":"2020-09-10","conditions":"Magnetic Resonance Imaging, Asymptomatic Intracranial Stenosis, Medical Treatment","enrollment":40},{"nctId":"NCT02347098","phase":"PHASE3","title":"Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase II","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2015-03-30","conditions":"Acute Coronary Artery Syndrome","enrollment":270},{"nctId":"NCT01004406","phase":"PHASE3","title":"Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase I","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2011-09","conditions":"Acute Coronary Syndrome","enrollment":59}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Atorvastatin or other equivalent types of statin"],"phase":"phase_3","status":"active","brandName":"standard statin monotherapy","genericName":"standard statin monotherapy","companyName":"VA Office of Research and Development","companyId":"va-office-of-research-and-development","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Standard statin monotherapy works by inhibiting HMG-CoA reductase, a key enzyme in the cholesterol biosynthesis pathway. Used for Hypercholesterolemia, Atherosclerotic cardiovascular disease.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}